gene_symbol,transcript_id,expression_fold_change,chromosome,pathways,go_biological_process,drug_count
ABL1,ENST00000318560,3.472,chr9,,actin cytoskeleton organization,15
ACTB,ENST00000432588,1.29,chr7,Adherens junctions interactions|ATP-dependent chromatin remodelers|Axon guidance|B-WICH complex positively regulates rRNA expression|Cell-Cell communication|Cell-cell junction organization|Cell-extracellular matrix interactions|Cell junction organization|Chaperonin-mediated protein folding|Chromatin modifying enzymes|Chromatin organization|Clathrin-mediated endocytosis|Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding|Deubiquitination|Developmental Biology|Disease|Diseases of s,adherens junction assembly,0
AKT1,ENST00000349310,1.25,chr14,"Activation of BAD and translocation to mitochondria|Activation of BH3-only proteins|Adaptive Immune System|AKT-mediated inactivation of FOXO1A|AKT phosphorylates targets in the cytosol|AKT phosphorylates targets in the nucleus|Apoptosis|Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA|CD28 dependent PI3K/Akt signaling|Cell Cycle|Cell Cycle, Mitotic|Cellular responses to mechanical stimuli|Cellular responses to stimuli|Cellular responses to stress|Cellular response to chemical stress",activation-induced cell death of T cells,0
ALK,ENST00000389048,3.918,chr2,alectinib-resistant ALK mutants|ALK mutants bind TKIs|ASP-3026-resistant ALK mutants|brigatinib-resistant ALK mutants|ceritinib-resistant ALK mutants|crizotinib-resistant ALK mutants|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Drug resistance of ALK mutants|lorlatinib-resistant ALK mutants|MDK and PTN in ALK signaling|NVP-TAE684-resistant ALK mutants|Signaling by ALK|Signaling by ALK fusions and activated point mutants|Signaling by ALK in cancer|Signa,cell surface receptor protein tyrosine kinase signaling pathway,7
AMER1,ENST00000374869,3.004,chrX,APC truncation mutants have impaired AXIN binding|AXIN missense mutants destabilize the destruction complex|Beta-catenin phosphorylation cascade|Cellular responses to stimuli|Cellular responses to stress|Cellular response to chemical stress|CTNNB1 S33 mutants aren't phosphorylated|CTNNB1 S37 mutants aren't phosphorylated|CTNNB1 S45 mutants aren't phosphorylated|CTNNB1 T41 mutants aren't phosphorylated|Degradation of beta-catenin by the destruction complex|Disassembly of the destruction complex a,negative regulation of canonical Wnt signaling pathway,0
APBB1IP,ENST00000356785,0.59,chr10,"Disease|Diseases of signal transduction by growth factor receptors and second messengers|GRB2:SOS provides linkage to MAPK signaling for Integrins|Hemostasis|Integrin signaling|MAP2K and MAPK activation|MAPK1/MAPK3 signaling|MAPK family signaling cascades|Oncogenic MAPK signaling|p130Cas linkage to MAPK signaling for integrins|Paradoxical activation of RAF signaling by kinase inactive BRAF|Platelet activation, signaling and aggregation|Platelet Aggregation (Plug Formation)|RAF/MAP kinase cascade",intracellular signal transduction,0
APC,ENST00000257430,0.312,chr5,,bicellular tight junction assembly,0
AR,ENST00000374690,0.532,chrX,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3|Cellular responses to stimuli|Cellular responses to stress|Deubiquitination|Gene expression (Transcription)|Generic Transcription Pathway|HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand|Metabolism of proteins|Nuclear Receptor transcription pathway|Post-translational protein modification|RHO GTPase Effectors|RHO GTPases activate PKNs|RNA Polymerase II Transcription|R,androgen receptor signaling pathway,13
ARID1A,ENST00000324856,0.407,chr1,,chromatin organization,0
ARID2,ENST00000334344,0.751,chr12,ATP-dependent chromatin remodelers|Chromatin modifying enzymes|Chromatin organization|Formation of the polybromo-BAF (pBAF) complex|Gene expression (Transcription)|Generic Transcription Pathway|RMTs methylate histone arginines|RNA Polymerase II Transcription|RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known|SWI/SNF chromatin remodelers|Transcriptional regulation by RUNX1,chromatin organization,0
ARRB1,ENST00000360025,0.96,chr11,Activated NOTCH1 Transmits Signal to the Nucleus|Activation of SMO|Cargo recognition for clathrin-mediated endocytosis|Clathrin-mediated endocytosis|Deubiquitination|Disease|Diseases of signal transduction by growth factor receptors and second messengers|G alpha (s) signalling events|Golgi Associated Vesicle Biogenesis|GPCR downstream signalling|Hedgehog 'on' state|Hemostasis|Lysosome Vesicle Biogenesis|MAP2K and MAPK activation|MAPK1/MAPK3 signaling|MAPK family signaling cascades|Membrane Traff,cell surface receptor signaling pathway,0
ATM,ENST00000278616,3.804,chr11,Autodegradation of the E3 ubiquitin ligase COP1|Autophagy|Cell Cycle|Cell Cycle Checkpoints|Cellular responses to stimuli|Cellular responses to stress|Cellular response to heat stress|Cellular Senescence|Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function|Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function|Defective homologous recombination repair (HRR) due to BRCA1 loss of functi,cellular response to gamma radiation,0
ATR,ENST00000350721,0.468,chr3,Activation of ATR in response to replication stress|Cell Cycle|Cell Cycle Checkpoints|Cellular responses to stimuli|Cellular responses to stress|Cellular response to heat stress|Defective homologous recombination repair (HRR) due to BRCA2 loss of function|Disease|Diseases of DNA Double-Strand Break Repair|Diseases of DNA repair|DNA Double-Strand Break Repair|DNA Repair|Fanconi Anemia Pathway|G2/M Checkpoints|G2/M DNA damage checkpoint|Gene expression (Transcription)|Generic Transcription Pathway,cellular response to gamma radiation,0
AXIN1,ENST00000262320,1.338,chr16,,apoptotic process,0
AXIN2,ENST00000307078,0.412,chr17,Binding of TCF/LEF:CTNNB1 to target gene promoters|Degradation of AXIN|Deubiquitination|Formation of the beta-catenin:TCF transactivating complex|Metabolism of proteins|Post-translational protein modification|Signaling by WNT|Signal Transduction|TCF dependent signaling in response to WNT|Ub-specific processing proteases,aortic valve morphogenesis,0
BAP1,ENST00000296288,2.085,chr3,Deubiquitination|DNA Double-Strand Break Repair|DNA Double Strand Break Response|DNA Repair|Metabolism of proteins|Post-translational protein modification|Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks|UCH proteinases,cell differentiation,0
BARD1,ENST00000260947,3.663,chr2,,cellular response to ionizing radiation,0
BCL9L,ENST00000334801,0.897,chr11,Deactivation of the beta-catenin transactivating complex|Formation of the beta-catenin:TCF transactivating complex|Signaling by WNT|Signal Transduction|TCF dependent signaling in response to WNT,canonical Wnt signaling pathway,0
BCR,ENST00000305877,0.615,chr22,,activation of GTPase activity,11
BMP2,ENST00000378827,4.437,chr20,Elastic fibre formation|Extracellular matrix organization|Gene expression (Transcription)|Generic Transcription Pathway|Molecules associated with elastic fibres|Regulation of RUNX2 expression and activity|RNA Polymerase II Transcription|Signaling by BMP|Signaling by TGFB family members|Signal Transduction|Transcriptional regulation by RUNX2,animal organ morphogenesis,0
BRAF,ENST00000288602,1.245,chr7,ARMS-mediated activation|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Frs2-mediated activation|Gain-of-function MRAS complexes activate RAF signaling|MAP2K and MAPK activation|MAPK1/MAPK3 signaling|MAPK family signaling cascades|Negative feedback regulation of MAPK pathway|Negative regulation of FGFR1 signaling|Negative regulation of FGFR2 signaling|Negative regulation of FGFR3 signaling|Negative regulation of FGFR4 signaling|Negative regulation of MAP,animal organ morphogenesis,7
BRCA1,ENST00000352993,0.422,chr17,,cellular response to indole-3-methanol,0
BRCA2,ENST00000380152,0.303,chr13,Cell Cycle|Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function|Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function|Defective homologous recombination repair (HRR) due to BRCA1 loss of function|Defective homologous recombination repair (HRR) due to BRCA2 loss of function|Defective homologous recombination repair (HRR) due to PALB2 loss of function|Disease|Diseases of DNA Double-Str,cellular response to ionizing radiation,0
BRIP1,ENST00000259008,1.351,chr17,Cell Cycle|Cell Cycle Checkpoints|Cytosolic iron-sulfur cluster assembly|Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function|Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function|Defective homologous recombination repair (HRR) due to BRCA1 loss of function|Defective homologous recombination repair (HRR) due to BRCA2 loss of function|Defective homologous recombination repair (HRR) du,DNA damage checkpoint signaling,0
C11orf65,ENST00000393084,3.488,chr11,,,0
CASP8,ENST00000264275,5.353,chr2,,angiogenesis,0
CCDC6,ENST00000263102,0.325,chr10,,cytoskeleton organization,2
CD274,ENST00000381573,4.969,chr9,,adaptive immune response,4
CDC37,ENST00000222005,0.701,chr19,Constitutive Signaling by EGFRvIII|Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants|Constitutive Signaling by Overexpressed ERBB2|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downregulation of ERBB2 signaling|Drug-mediated inhibition of ERBB2 signaling|Drug resistance in ERBB2 KD mutants|Drug resistance in ERBB2 TMD/JMD mutants|Programmed Cell Death|Regulated Necrosis|Regulation of necroptotic cell death|Resistance of ERBB2 KD mutants t,positive regulation of type 2 mitophagy,0
CDC73,ENST00000367435,0.794,chr1,E3 ubiquitin ligases ubiquitinate target proteins|Formation of RNA Pol II elongation complex|Formation of the beta-catenin:TCF transactivating complex|Gene expression (Transcription)|Hedgehog 'on' state|Metabolism of proteins|Post-translational protein modification|Protein ubiquitination|RNA Polymerase II Pre-transcription Events|RNA Polymerase II Transcription|RNA Polymerase II Transcription Elongation|Signaling by Hedgehog|Signaling by WNT|Signal Transduction|TCF dependent signaling in respons,cellular response to lipopolysaccharide,0
CDH1,ENST00000261769,0.775,chr16,,adherens junction organization,0
CDK12,ENST00000430627,1.248,chr17,Gene expression (Transcription)|Generic Transcription Pathway|RNA Polymerase II Transcription|TP53 Regulates Transcription of DNA Repair Genes|Transcriptional Regulation by TP53,cellular response to estrogen stimulus,0
CDK4,ENST00000257904,1.178,chr12,"Aberrant regulation of mitotic cell cycle due to RB1 defects|Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects|Adaptive Immune System|Adipogenesis|Cell Cycle|Cell Cycle, Mitotic|Cellular responses to stimuli|Cellular responses to stress|Cellular Senescence|Chromatin modifying enzymes|Chromatin organization|Co-inhibition by PD-1|Cyclin A:Cdk2-associated events at S phase entry|Cyclin D associated events in G1|Cyclin E associated events during G1/S transition|Defective bi",cell division,6
CDK6,ENST00000265734,1.206,chr7,"Aberrant regulation of mitotic cell cycle due to RB1 defects|Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects|Cell Cycle|Cell Cycle, Mitotic|Cellular responses to stimuli|Cellular responses to stress|Cellular Senescence|Cyclin D associated events in G1|Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)|Disease|Diseases of cellular response to stress|Diseases of Cellular Senescence|Diseases of mitotic cell cycle|Drug-mediated inhibition of CDK4/CDK6 activity|Evasion ",astrocyte development,6
CDKN2A,ENST00000304494,1.333,chr9,"Apoptosis|Apoptotic factor-mediated response|Cell Cycle|Cell Cycle Checkpoints|Cell Cycle, Mitotic|Cellular responses to stimuli|Cellular responses to stress|Cellular response to chemical stress|Cellular Senescence|Cyclin D associated events in G1|Defective Intrinsic Pathway for Apoptosis|Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function|Developmental Biology|Disease|Diseases of cellular response to stress|Diseases of Cellular Senescence|Diseases of programmed cell death|E",cellular senescence,0
CHEK2,ENST00000348295,0.43,chr22,Cell Cycle|Cell Cycle Checkpoints|Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex|DNA Double-Strand Break Repair|DNA Double Strand Break Response|DNA Repair|G1/S DNA Damage Checkpoints|G2/M Checkpoints|G2/M DNA damage checkpoint|Gene expression (Transcription)|Generic Transcription Pathway|p53-Dependent G1 DNA Damage Response|p53-Dependent G1/S DNA damage checkpoint|p53-Independent G1/S DNA Damage Checkpoint|Recruitment and ATM-mediated phosphorylation of repair and signaling prot,apoptotic process,0
CNKSR2,ENST00000279451,4.232,chrX,Disease|Diseases of signal transduction by growth factor receptors and second messengers|MAP2K and MAPK activation|MAPK1/MAPK3 signaling|MAPK family signaling cascades|Oncogenic MAPK signaling|Paradoxical activation of RAF signaling by kinase inactive BRAF|RAF/MAP kinase cascade|Signaling by BRAF and RAF1 fusions|Signaling by high-kinase activity BRAF mutants|Signaling by moderate kinase activity BRAF mutants|Signaling by RAF1 mutants|Signaling by RAS mutants|Signaling downstream of RAS mutants|,enzyme-linked receptor protein signaling pathway,0
CSF1R,ENST00000286301,1.189,chr5,Cytokine Signaling in Immune system|Gene expression (Transcription)|Generic Transcription Pathway|Immune System|Other interleukin signaling|RNA Polymerase II Transcription|Signaling by CSF1 (M-CSF) in myeloid cells|Signaling by Interleukins|Transcriptional Regulation by VENTX,anatomical structure morphogenesis,7
CSK,ENST00000220003,0.437,chr15,Adaptive Immune System|Co-inhibition by PD-1|Cytokine Signaling in Immune system|Disease|Diseases of signal transduction by growth factor receptors and second messengers|FLT3 Signaling|GAB1 signalosome|Hemostasis|Immune System|Integrin signaling|MAP2K and MAPK activation|MAPK1/MAPK3 signaling|MAPK family signaling cascades|Negative regulation of FLT3|Oncogenic MAPK signaling|Paradoxical activation of RAF signaling by kinase inactive BRAF|Phosphorylation of CD3 and TCR zeta chains|Platelet activa,adaptive immune response,0
CTNNA1,ENST00000302763,3.0,chr5,Adherens junctions interactions|CDH11 homotypic and heterotypic interactions|Cell-Cell communication|Cell-cell junction organization|Cell junction organization|Degradation of CDH1|Developmental Biology|Myogenesis|Regulation of CDH11 Expression and Function|Regulation of CDH11 function|Regulation of CDH19 Expression and Function|Regulation of CDH1 Expression and Function|Regulation of CDH1 Function|Regulation of Expression and Function of Type I Classical Cadherins|Regulation of Expression and Fu,apical junction assembly,0
CTNNB1,ENST00000349496,3.821,chr3,Adaptive Immune System|Adherens junctions interactions|Apoptosis|Apoptotic cleavage of cell adhesion  proteins|Apoptotic cleavage of cellular proteins|Apoptotic execution phase|Bacterial Infection Pathways|Beta-catenin independent WNT signaling|Beta-catenin phosphorylation cascade|Binding of TCF/LEF:CTNNB1 to target gene promoters|Ca2+ pathway|Cardiogenesis|CDH11 homotypic and heterotypic interactions|Cell-Cell communication|Cell-cell junction organization|Cell junction organization|Cellular res,adherens junction assembly,0
CYP19A1,ENST00000396402,3.119,chr15,Biological oxidations|Cytochrome P450 - arranged by substrate type|Defective CYP19A1 causes AEXS|Disease|Diseases of metabolism|Endogenous sterols|Estrogen biosynthesis|Metabolic disorders of biological oxidation enzymes|Metabolism|Metabolism of lipids|Metabolism of steroid hormones|Metabolism of steroids|Phase I - Functionalization of compounds,androgen catabolic process,4
DDR2,ENST00000367921,0.369,chr1,Extracellular matrix organization|Non-integrin membrane-ECM interactions,biomineral tissue development,1
DHFR,ENST00000439211,4.429,chr5,"Cell Cycle|Cell Cycle, Mitotic|G1/S-Specific Transcription|G1/S Transition|Metabolism|Metabolism of cofactors|Metabolism of folate and pterines|Metabolism of vitamins and cofactors|Metabolism of water-soluble vitamins and cofactors|Mitotic G1 phase and G1/S transition|Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation",axon regeneration,7
DNMT1,ENST00000340748,0.892,chr19,Defective pyroptosis|Disease|Diseases of programmed cell death|Diseases of signal transduction by growth factor receptors and second messengers|DNA methylation|Epigenetic regulation of gene expression|Gene expression (Transcription)|Metabolism of proteins|Negative epigenetic regulation of rRNA expression|NoRC negatively regulates rRNA expression|Nuclear events stimulated by ALK signaling in cancer|Post-translational protein modification|PRC2 methylates histones and DNA|Signaling by ALK|Signaling,chromatin organization,2
EGF,ENST00000265171,0.571,chr4,Cargo recognition for clathrin-mediated endocytosis|Cellular responses to stimuli|Cellular responses to stress|Cellular response to chemical stress|Clathrin-mediated endocytosis|Constitutive Signaling by Aberrant PI3K in Cancer|Constitutive Signaling by EGFRvIII|Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants|Developmental Biology|Developmental Cell Lineages|Developmental Cell Lineages of the Exocrine Pancreas|Developmental Cell Lineages of the Integumentary System|Developmental,angiogenesis,0
EGFR,ENST00000275493,4.156,chr7,,cell-cell adhesion,25
ELAC2,ENST00000338034,0.403,chr17,"Gene expression (Transcription)|Gene Silencing by RNA|Metabolism of RNA|rRNA processing|rRNA processing in the mitochondrion|tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis|tRNA processing|tRNA processing in the mitochondrion|tRNA processing in the nucleus",mitochondrial tRNA 3'-end processing,0
EML4,ENST00000318522,0.752,chr2,"ALK mutants bind TKIs|Cell Cycle|Cell Cycle, Mitotic|Disease|Diseases of signal transduction by growth factor receptors and second messengers|EML4 and NUDC in mitotic spindle formation|Mitotic Prometaphase|M Phase|Signaling by ALK fusions and activated point mutants|Signaling by ALK in cancer",attachment of spindle microtubules to kinetochore,5
EPAS1,ENST00000263734,0.648,chr2,Adaptive Immune System|Autophagy|Cellular responses to stimuli|Cellular responses to stress|Cellular response to hypoxia|Co-inhibition by PD-1|Developmental Biology|Immune System|Macroautophagy|Metabolism of proteins|Neddylation|Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha|Pexophagy|Post-translational protein modification|PTK6 Expression|Regulation of gene expression by Hypoxia-inducible Factor|Regulation of PD-L1(CD274) expression|Regulation of PD-L1(CD274) transcrip,angiogenesis,1
EPCAM,ENST00000263735,1.348,chr2,Attachment of bacteria to epithelial cells|Bacterial Infection Pathways|Biofilm formation|Cell surface interactions at the vascular wall|Developmental Biology|Developmental Cell Lineages|Developmental Cell Lineages of the Integumentary System|Developmental Lineage of Mammary Gland Alveolar Cells|Developmental Lineage of Mammary Gland Luminal Epithelial Cells|Developmental Lineage of Mammary Gland Myoepithelial Cells|Developmental Lineage of Mammary Stem Cells|Developmental Lineages of the Mammar,cell-cell adhesion,1
EPHA2,ENST00000358432,2.021,chr1,"Axon guidance|Developmental Biology|EPHA-mediated growth cone collapse|EPH-ephrin mediated repulsion of cells|EPH-Ephrin signaling|Nervous system development|RAC1 GTPase cycle|RAC2 GTPase cycle|RAC3 GTPase cycle|RHOG GTPase cycle|RHO GTPase cycle|RHOU GTPase cycle|RHOV GTPase cycle|RND1 GTPase cycle|RND2 GTPase cycle|RND3 GTPase cycle|Signaling by Rho GTPases|Signaling by Rho GTPases, Miro GTPases and RHOBTB3|Signal Transduction",angiogenesis,3
ERBB2,ENST00000269571,1.834,chr17,Axon guidance|Constitutive Signaling by Aberrant PI3K in Cancer|Constitutive Signaling by Overexpressed ERBB2|Developmental Biology|Developmental Cell Lineages|Developmental Cell Lineages of the Integumentary System|Developmental Lineage of Mammary Gland Luminal Epithelial Cells|Developmental Lineage of Mammary Gland Myoepithelial Cells|Developmental Lineage of Mammary Stem Cells|Developmental Lineages of the Mammary Gland|Disease|Diseases of signal transduction by growth factor receptors and se,cell population proliferation,17
ERBB3,ENST00000267101,4.637,chr12,Constitutive Signaling by Aberrant PI3K in Cancer|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downregulation of ERBB2:ERBB3 signaling|Downregulation of ERBB2 signaling|ERBB2 Activates PTK6 Signaling|ERBB2 Regulates Cell Motility|GRB7 events in ERBB2 signaling|Intracellular signaling by second messengers|MAPK1/MAPK3 signaling|MAPK family signaling cascades|Negative regulation of the PI3K/AKT network|PI3K/AKT Signaling in Cancer|PI3K events in ERBB2 sig,cell surface receptor protein tyrosine kinase signaling pathway,1
ERBB4,ENST00000260943,1.47,chr2,Activation of NMDA receptors and postsynaptic events|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downregulation of ERBB2 signaling|Downregulation of ERBB4 signaling|ERBB2 Activates PTK6 Signaling|ERBB2 Regulates Cell Motility|ESR-mediated signaling|Estrogen-dependent gene expression|GRB2 events in ERBB2 signaling|Long-term potentiation|MAPK1/MAPK3 signaling|MAPK family signaling cascades|Neuronal System|Neurotransmitter receptors and postsynaptic sign,apoptotic process,7
EREG,ENST00000244869,0.674,chr4,Cargo recognition for clathrin-mediated endocytosis|Clathrin-mediated endocytosis|Constitutive Signaling by Aberrant PI3K in Cancer|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downregulation of ERBB2 signaling|EGFR downregulation|EGFR interacts with phospholipase C-gamma|ERBB2 Activates PTK6 Signaling|ERBB2 Regulates Cell Motility|ESR-mediated signaling|Estrogen-dependent nuclear events downstream of ESR-membrane signaling|Extra-nuclear estrogen signa,anatomical structure morphogenesis,0
ESR1,ENST00000206249,0.602,chr6,,cellular response to estradiol stimulus,14
ESR2,ENST00000267525,2.768,chr14,,cell-cell signaling,11
EXO1,ENST00000348581,0.315,chr1,,DNA damage response,0
FAT1,ENST00000441802,4.377,chr4,,anatomical structure morphogenesis,0
FBXO11,ENST00000402508,0.383,chr2,Adaptive Immune System|Antigen processing: Ubiquitination & Proteasome degradation|Class I MHC mediated antigen processing & presentation|Immune System|Metabolism of proteins|Neddylation|Post-translational protein modification,negative regulation of epithelial to mesenchymal transition,0
FBXW7,ENST00000281708,0.364,chr4,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants|Constitutive Signaling by NOTCH1 PEST Domain Mutants|Disease|Diseases of signal transduction by growth factor receptors and second messengers|FBXW7 Mutants and NOTCH1 in Cancer|Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling|Negative regulation of NOTCH4 signaling|NOTCH1 Intracellular Domain Regulates Transcription|Signaling by NOTCH|Signaling by NOTCH1|Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer|Signaling by NOTCH1 in Can,DNA damage response,0
FGF1,ENST00000337706,0.313,chr5,Activated point mutants of FGFR2|Constitutive Signaling by Aberrant PI3K in Cancer|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downstream signaling of activated FGFR1|Downstream signaling of activated FGFR2|Downstream signaling of activated FGFR3|Downstream signaling of activated FGFR4|FGFR1b ligand binding and activation|FGFR1c ligand binding and activation|FGFR1 ligand binding and activation|FGFR1 mutant receptor activation|FGFR2b ligand binding and,activation of protein kinase B activity,0
FGF10,ENST00000264664,3.975,chr5,Activated point mutants of FGFR2|Constitutive Signaling by Aberrant PI3K in Cancer|Developmental Biology|Developmental Cell Lineages|Developmental Cell Lineages of the Exocrine Pancreas|Developmental Cell Lineages of the Integumentary System|Developmental Lineage of Mammary Stem Cells|Developmental Lineage of Multipotent Pancreatic Progenitor Cells|Developmental Lineages of the Mammary Gland|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downstream signa,actin cytoskeleton organization,0
FGF18,ENST00000274625,4.25,chr5,Activated point mutants of FGFR2|Constitutive Signaling by Aberrant PI3K in Cancer|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downstream signaling of activated FGFR2|Downstream signaling of activated FGFR3|Downstream signaling of activated FGFR4|FGFR2c ligand binding and activation|FGFR2 ligand binding and activation|FGFR2 mutant receptor activation|FGFR3b ligand binding and activation|FGFR3c ligand binding and activation|FGFR3 ligand binding and act,anatomical structure morphogenesis,0
FGF2,ENST00000264498,3.616,chr4,Activated point mutants of FGFR2|Constitutive Signaling by Aberrant PI3K in Cancer|Cytokine Signaling in Immune system|Developmental Biology|Developmental Cell Lineages|Developmental Cell Lineages of the Exocrine Pancreas|Developmental Lineage of Multipotent Pancreatic Progenitor Cells|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downstream signaling of activated FGFR1|Downstream signaling of activated FGFR2|Downstream signaling of activated FGFR3|Down,angiogenesis,0
FGF23,ENST00000237837,3.327,chr12,Activated point mutants of FGFR2|Constitutive Signaling by Aberrant PI3K in Cancer|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downstream signaling of activated FGFR1|Downstream signaling of activated FGFR2|Downstream signaling of activated FGFR3|Downstream signaling of activated FGFR4|FGFR1c and Klotho ligand binding and activation|FGFR1c ligand binding and activation|FGFR1 ligand binding and activation|FGFR1 mutant receptor activation|FGFR2c ligand ,calcium ion homeostasis,0
FGF9,ENST00000382353,3.144,chr13,Activated point mutants of FGFR2|Constitutive Signaling by Aberrant PI3K in Cancer|Developmental Biology|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downstream signaling of activated FGFR1|Downstream signaling of activated FGFR2|Downstream signaling of activated FGFR3|Downstream signaling of activated FGFR4|FGFR1c ligand binding and activation|FGFR1 ligand binding and activation|FGFR1 mutant receptor activation|FGFR2c ligand binding and activation|FGF,cell-cell signaling,0
FGFR1,ENST00000326324,1.096,chr8,,calcium ion homeostasis,8
FGFR2,ENST00000346997,1.391,chr10,Disease|Diseases of signal transduction by growth factor receptors and second messengers|FGFR2 mutant receptor activation|Signaling by FGFR2 amplification mutants|Signaling by FGFR2 in disease|Signaling by FGFR in disease,angiogenesis,6
FGFR3,ENST00000340107,2.287,chr4,Constitutive Signaling by Aberrant PI3K in Cancer|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downstream signaling of activated FGFR3|FGFR3b ligand binding and activation|FGFR3 ligand binding and activation|FGFR3 mutant receptor activation|FRS-mediated FGFR3 signaling|IGF1R signaling cascade|Insulin receptor signalling cascade|Intracellular signaling by second messengers|IRS-mediated signalling|IRS-related events triggered by IGF1R|MAPK1/MAPK3 signali,apoptotic process,8
FGFR4,ENST00000292408,3.888,chr5,betaKlotho-mediated ligand binding|Constitutive Signaling by Aberrant PI3K in Cancer|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downstream signaling of activated FGFR4|FGFR4 ligand binding and activation|FGFR4 mutant receptor activation|FRS-mediated FGFR4 signaling|IGF1R signaling cascade|Insulin receptor signalling cascade|Intracellular signaling by second messengers|IRS-mediated signalling|IRS-related events triggered by IGF1R|MAPK1/MAPK3 signaling,cell migration,4
FH,ENST00000366560,1.077,chr1,Aerobic respiration and respiratory electron transport|Citric acid cycle (TCA cycle)|Metabolism|Metabolism of proteins|Mitochondrial protein degradation,arginine metabolic process,0
FLCN,ENST00000285071,0.691,chr17,Amino acids regulate mTORC1|Cellular responses to stimuli|Cellular responses to stress|Cellular response to starvation,cell-cell junction assembly,0
FLT1,ENST00000282397,0.677,chr13,Neurophilin interactions with VEGF and VEGFR|Signaling by Receptor Tyrosine Kinases|Signaling by VEGF|Signal Transduction|VEGF binds to VEGFR leading to receptor dimerization|VEGF ligand-receptor interactions,angiogenesis,14
FLT3,ENST00000241453,0.98,chr13,Constitutive Signaling by Aberrant PI3K in Cancer|crenolanib-resistant FLT3 mutants|Cytokine Signaling in Immune system|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Drug resistance of FLT3 mutants|FLT3 mutants bind TKIs|FLT3 Signaling|FLT3 signaling by CBL mutants|FLT3 signaling in disease|FLT3 signaling through SRC family kinases|gilteritinib-resistant FLT3 mutants|IGF1R signaling cascade|Immune System|Insulin receptor signalling cascade|Intracellular,B cell differentiation,12
FLT4,ENST00000261937,2.533,chr5,Cellular responses to mechanical stimuli|Cellular responses to stimuli|High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells|NOTCH4 Intracellular Domain Regulates Transcription|Response of endothelial cells to shear stress|Signaling by NOTCH|Signaling by NOTCH4|Signaling by Receptor Tyrosine Kinases|Signaling by VEGF|Signal Transduction|VEGF binds to VEGFR leading to receptor dimerization|VEGF ligand-receptor interactions,angiogenesis,15
FN1,ENST00000323926,4.343,chr2,,acute-phase response,0
FOXA1,ENST00000250448,0.409,chr14,Developmental Biology|ESR-mediated signaling|Estrogen-dependent gene expression|Formation of axial mesoderm|Gastrulation|Signaling by Nuclear Receptors|Signal Transduction,anatomical structure morphogenesis,0
FRK,ENST00000606080,0.683,chr6,Immune System|Innate Immune System|Intracellular signaling by second messengers|Neutrophil degranulation|PIP3 activates AKT signaling|PTEN Regulation|Regulation of PTEN stability and activity|Signal Transduction,cell differentiation,2
GAB2,ENST00000340149,4.125,chr11,,cell surface receptor protein tyrosine kinase signaling pathway,0
GALNT12,ENST00000375011,0.924,chr9,Defective GALNT12 causes CRCS1|Disease|Diseases associated with O-glycosylation of proteins|Diseases of glycosylation|Diseases of metabolism|Metabolism of proteins|O-linked glycosylation|O-linked glycosylation of mucins|Post-translational protein modification,protein O-linked glycosylation,0
GART,ENST00000361093,1.477,chr21,Metabolism|Metabolism of nucleotides|Nucleotide biosynthesis|Purine ribonucleoside monophosphate biosynthesis,adenine biosynthetic process,4
GATA3,ENST00000346208,2.09,chr10,Cytokine Signaling in Immune system|Deubiquitination|Developmental Biology|Developmental Cell Lineages|Developmental Cell Lineages of the Integumentary System|Developmental Lineage of Mammary Stem Cells|Developmental Lineages of the Mammary Gland|ESR-mediated signaling|Estrogen-dependent gene expression|Factors involved in megakaryocyte development and platelet production|Formation of the nephric duct|Gene expression (Transcription)|Generic Transcription Pathway|Hemostasis|Immune System|Interleu,anatomical structure formation involved in morphogenesis,0
GNRHR,ENST00000226413,4.371,chr4,Class A/1 (Rhodopsin-like receptors)|G alpha (q) signalling events|GPCR downstream signalling|GPCR ligand binding|Hormone ligand-binding receptors|Signaling by GPCR|Signal Transduction,cellular response to gonadotropin-releasing hormone,14
GRB2,ENST00000316615,1.108,chr17,Activated NTRK2 signals through FRS2 and FRS3|Activated NTRK2 signals through PI3K|Activated NTRK2 signals through RAS|Activated NTRK3 signals through RAS|Adaptive Immune System|Antigen activates B Cell Receptor (BCR) leading to generation of second messengers|Axon guidance|Bacterial Infection Pathways|Cargo recognition for clathrin-mediated endocytosis|CD28 dependent Vav1 pathway|Cell-Cell communication|Cell surface interactions at the vascular wall|Clathrin-mediated endocytosis|Co-inhibition b,actin cytoskeleton organization,0
HRAS,ENST00000311189,0.899,chr11,Activated NTRK2 signals through FRS2 and FRS3|Activated NTRK2 signals through RAS|Activated NTRK3 signals through RAS|Activation of NMDA receptors and postsynaptic events|Activation of RAS in B cells|Adaptive Immune System|Axon guidance|CD209 (DC-SIGN) signaling|Cell surface interactions at the vascular wall|Constitutive Signaling by EGFRvIII|Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants|Constitutive Signaling by Overexpressed ERBB2|CREB1 phosphorylation through NMDA receptor-,adipose tissue development,0
HSP90AA1,ENST00000216281,0.614,chr14,"Aggrephagy|Anchoring of the basal body to the plasma membrane|Assembly and release of respiratory syncytial virus (RSV) virions|Attenuation phase|AURKA Activation by TPX2|Autophagy|Axon guidance|Bacterial Infection Pathways|Binding and Uptake of Ligands by Scavenger Receptors|Cell Cycle|Cell Cycle, Mitotic|Cellular responses to stimuli|Cellular responses to stress|Cellular response to heat stress|Centrosome maturation|Chaperone Mediated Autophagy|Cilium Assembly|Constitutive Signaling by EGFRvII",activation of innate immune response,0
IDH1,ENST00000345146,4.704,chr2,Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate|Cellular responses to stimuli|Cellular responses to stress|Cellular response to chemical stress|Disease|Diseases of metabolism|Immune System|Innate Immune System|KEAP1-NFE2L2 pathway|Metabolism|Metabolism of cofactors|Metabolism of vitamins and cofactors|NADPH regeneration|Neutrophil degranulation|NFE2L2 regulating TCA cycle genes|Nuclear events mediated by NFE2L2|Peroxisomal protein import|Protein localization,2-oxoglutarate metabolic process,2
IQGAP1,ENST00000268182,1.24,chr15,CDC42 GTPase cycle|Cell-Cell communication|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Glucagon-like Peptide-1 (GLP1) regulates insulin secretion|Immune System|Innate Immune System|Integration of energy metabolism|MAP2K and MAPK activation|MAPK1/MAPK3 signaling|MAPK family signaling cascades|Metabolism|Nephrin family interactions|Neutrophil degranulation|Oncogenic MAPK signaling|Paradoxical activation of RAF signaling by kinase inactive BRAF|RAC1 GTPa,caveola assembly,0
ITGB3,ENST00000559488,5.443,chr17,Axon guidance|Cell surface interactions at the vascular wall|Cellular responses to mechanical stimuli|Cellular responses to stimuli|Developmental Biology|Disease|Diseases of signal transduction by growth factor receptors and second messengers|ECM proteoglycans|Elastic fibre formation|Extracellular matrix organization|GRB2:SOS provides linkage to MAPK signaling for Integrins|Hemostasis|Integrin cell surface interactions|Integrin signaling|L1CAM interactions|MAP2K and MAPK activation|MAPK1/MAPK3 s,angiogenesis,0
KDM5C,ENST00000375379,1.076,chrX,Chromatin modifying enzymes|Chromatin organization|HDMs demethylate histones,chromatin organization,0
KDM6A,ENST00000377967,0.485,chrX,Activation of anterior HOX genes in hindbrain development during early embryogenesis|Activation of HOX genes during differentiation|Chromatin modifications during the maternal to zygotic transition (MZT)|Chromatin modifying enzymes|Chromatin organization|Developmental Biology|Epigenetic regulation by WDR5-containing histone modifying complexes|Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes|Epigenetic regulation of gene expression|Epigenetic regulation of gene expression b,chromatin organization,0
KDR,ENST00000263923,3.218,chr4,Cellular responses to mechanical stimuli|Cellular responses to stimuli|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Extracellular matrix organization|High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells|Integrin cell surface interactions|Neurophilin interactions with VEGF and VEGFR|Response of endothelial cells to shear stress|Signaling by membrane-tethered fusions of PDGFRA or PDGFRB|Signaling by PDGFR ,angiogenesis,21
KEAP1,ENST00000171111,0.471,chr19,Adaptive Immune System|Antigen processing: Ubiquitination & Proteasome degradation|Cellular responses to stimuli|Cellular responses to stress|Cellular response to chemical stress|Class I MHC mediated antigen processing & presentation|Deubiquitination|Disease|Immune System|Infectious disease|KEAP1-NFE2L2 pathway|Metabolism of proteins|Neddylation|Nuclear events mediated by NFE2L2|Post-translational protein modification|Potential therapeutics for SARS|SARS-CoV Infections|Ub-specific processing pro,cellular response to oxidative stress,0
KIF5B,ENST00000302418,1.385,chr10,Adaptive Immune System|COPI-dependent Golgi-to-ER retrograde traffic|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Factors involved in megakaryocyte development and platelet production|Golgi-to-ER retrograde transport|Hemostasis|Immune System|Insulin processing|Intra-Golgi and retrograde Golgi-to-ER traffic|Kinesins|Membrane Trafficking|Metabolism of proteins|MHC class II antigen presentation|Peptide hormone metabolism|RHO GTPase Effectors|RHO GTPases a,anterograde axonal protein transport,2
KIT,ENST00000288135,5.363,chr4,Constitutive Signaling by Aberrant PI3K in Cancer|Dasatinib-resistant KIT mutants|Developmental Biology|Developmental Cell Lineages|Developmental Cell Lineages of the Integumentary System|Developmental Lineage of Mammary Gland Alveolar Cells|Developmental Lineage of Mammary Gland Luminal Epithelial Cells|Developmental Lineages of the Mammary Gland|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Drug resistance of KIT mutants|Gene expression (Transcription,actin cytoskeleton organization,20
KLF6,ENST00000469435,0.714,chr10,,B cell differentiation,0
KMT2C,ENST00000262189,1.133,chr7,Activation of anterior HOX genes in hindbrain development during early embryogenesis|Activation of HOX genes during differentiation|Adaptive Immune System|Chromatin modifying enzymes|Chromatin organization|Co-inhibition by PD-1|Developmental Biology|Epigenetic regulation by WDR5-containing histone modifying complexes|Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes|Epigenetic regulation of gene expression|Epigenetic regulation of gene expression by MLL3 and MLL4 complexes|F,chromatin organization,0
KMT2D,ENST00000301067,1.478,chr12,Activation of anterior HOX genes in hindbrain development during early embryogenesis|Activation of HOX genes during differentiation|Chromatin modifying enzymes|Chromatin organization|Deactivation of the beta-catenin transactivating complex|Developmental Biology|Disease|Disorders of Developmental Biology|Epigenetic regulation by WDR5-containing histone modifying complexes|Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes|Epigenetic regulation of gene expression|Epigenetic reg,beta-catenin-TCF complex assembly,0
KRAS,ENST00000256078,8.234,chr12,Activated NTRK2 signals through FRS2 and FRS3|Activated NTRK2 signals through RAS|Activated NTRK3 signals through RAS|Activation of NMDA receptors and postsynaptic events|Activation of RAS in B cells|Adaptive Immune System|Axon guidance|CD209 (DC-SIGN) signaling|Cell surface interactions at the vascular wall|Constitutive Signaling by EGFRvIII|Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants|Constitutive Signaling by Overexpressed ERBB2|CREB1 phosphorylation through NMDA receptor-,cardiac muscle cell proliferation,2
LCK,ENST00000333070,4.829,chr1,Adaptive Immune System|CD28 dependent PI3K/Akt signaling|CD28 dependent Vav1 pathway|Cell surface interactions at the vascular wall|Co-inhibition by CTLA4|Co-inhibition by PD-1|Constitutive Signaling by Aberrant PI3K in Cancer|Co-stimulation by CD28|Cytokine Signaling in Immune system|DAP12 interactions|DAP12 signaling|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downstream TCR signaling|FLT3 Signaling|FLT3 signaling through SRC family kinases|Generati,B cell receptor signaling pathway,3
MAML3,ENST00000509479,0.542,chr4,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants|Constitutive Signaling by NOTCH1 PEST Domain Mutants|Developmental Biology|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Formation of paraxial mesoderm|Gastrulation|Gene expression (Transcription)|Generic Transcription Pathway|NOTCH1 Intracellular Domain Regulates Transcription|NOTCH2 intracellular domain regulates transcription|NOTCH3 Intracellular Domain Regulates Transcription|NOTCH4 Intracellul,Notch signaling pathway,0
MAP2K1,ENST00000307102,0.666,chr15,Axon guidance|Bacterial Infection Pathways|Cytokine Signaling in Immune system|Developmental Biology|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Frs2-mediated activation|Immune System|Infectious disease|Innate Immune System|Interleukin-17 signaling|Interleukin-1 family signaling|Interleukin-1 signaling|L1CAM interactions|MAP2K and MAPK activation|MAP3K8 (TPL2)-dependent MAPK1/3 activation|MAPK1/MAPK3 signaling|MAPK3 (ERK1) activation|MAPK family signa,cellular senescence,5
MAP2K2,ENST00000262948,4.981,chr19,Axon guidance|Bacterial Infection Pathways|Developmental Biology|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Frs2-mediated activation|Infectious disease|L1CAM interactions|MAP2K and MAPK activation|MAPK1 (ERK2) activation|MAPK1/MAPK3 signaling|MAPK family signaling cascades|Negative feedback regulation of MAPK pathway|Negative regulation of MAPK pathway|Nervous system development|Oncogenic MAPK signaling|Paradoxical activation of RAF signaling by kina,ERBB2-ERBB3 signaling pathway,5
MAPK1,ENST00000215832,0.906,chr22,"Activation of NMDA receptors and postsynaptic events|Activation of the AP-1 family of transcription factors|Adherens junctions interactions|Advanced glycosylation endproduct receptor signaling|Apoptosis|Apoptotic factor-mediated response|Axon guidance|Bacterial Infection Pathways|Ca-dependent events|Cell-Cell communication|Cell-cell junction organization|Cell Cycle|Cell Cycle, Mitotic|Cell junction organization|Cellular responses to stimuli|Cellular responses to stress|Cellular response to heat ",apoptotic process,0
MAPK11,ENST00000330651,1.009,chr22,activated TAK1 mediates p38 MAPK activation|Activation of PPARGC1A (PGC-1alpha) by phosphorylation|Activation of the AP-1 family of transcription factors|Cell Cycle|Cell Cycle Checkpoints|Cellular responses to stimuli|Cellular responses to stress|Cellular Senescence|Cytokine Signaling in Immune system|Developmental Biology|ERK/MAPK targets|G1/S DNA Damage Checkpoints|Gene expression (Transcription)|Generic Transcription Pathway|Immune System|Innate Immune System|Interleukin-17 signaling|KSRP (KH,bone development,1
MAPK3,ENST00000263025,0.605,chr16,"Cell Cycle|Cell Cycle, Mitotic|Golgi Cisternae Pericentriolar Stack Reorganization|Mitotic Prophase|M Phase",apoptotic process,0
MET,ENST00000318493,2.645,chr7,Axon guidance|Bacterial Infection Pathways|Constitutive Signaling by Aberrant PI3K in Cancer|Developmental Biology|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Drug-mediated inhibition of MET activation|Gene expression (Transcription)|Generic Transcription Pathway|Infectious disease|InlB-mediated entry of Listeria monocytogenes into host cell|Intracellular signaling by second messengers|Listeria monocytogenes entry into host cells|MAPK1/MAPK3 signaling,animal organ development,8
MLH1,ENST00000231790,0.912,chr3,Cell Cycle|Defective Mismatch Repair Associated With MLH1|Defective Mismatch Repair Associated With PMS2|Disease|Diseases of DNA repair|Diseases of Mismatch Repair (MMR)|DNA Repair|Gene expression (Transcription)|Generic Transcription Pathway|Meiosis|Meiotic recombination|Mismatch Repair|Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)|Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)|Reproduction|RNA Polymerase II Transcription|TP53 Regulates Transcription of DNA Repair Genes|Transc,DNA damage response,0
MPRIP,ENST00000341712,2.1,chr17,Disease|Diseases of signal transduction by growth factor receptors and second messengers|Oncogenic MAPK signaling|Signaling by BRAF and RAF1 fusions,,0
MSH2,ENST00000233146,0.891,chr2,Defective Mismatch Repair Associated With MSH2|Defective Mismatch Repair Associated With MSH3|Defective Mismatch Repair Associated With MSH6|Disease|Diseases of DNA repair|Diseases of Mismatch Repair (MMR)|DNA Repair|Gene expression (Transcription)|Generic Transcription Pathway|Mismatch Repair|Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)|Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)|RNA Polymerase II Transcription|TP53 Regulates Transcription of DNA Repair Genes|Transcription,B cell differentiation,0
MSH3,ENST00000265081,0.968,chr5,Defective Mismatch Repair Associated With MSH2|Defective Mismatch Repair Associated With MSH3|Disease|Diseases of DNA repair|Diseases of Mismatch Repair (MMR)|DNA Repair|Mismatch Repair|Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),DNA damage response,0
MSH6,ENST00000234420,0.945,chr2,Defective Mismatch Repair Associated With MSH2|Defective Mismatch Repair Associated With MSH6|Disease|Diseases of DNA repair|Diseases of Mismatch Repair (MMR)|DNA Repair|Mismatch Repair|Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),chromatin organization,0
MUTYH,ENST00000354383,4.792,chr1,"Base Excision Repair|Base-Excision Repair, AP Site Formation|Cleavage of the damaged purine|Defective Base Excision Repair Associated with MUTYH|Defective MUTYH substrate processing|Depurination|Disease|Diseases of Base Excision Repair|Diseases of DNA repair|Displacement of DNA glycosylase by APEX1|DNA Repair|Recognition and association of DNA glycosylase with site containing an affected purine|Resolution of Abasic Sites (AP sites)",base-excision repair,0
MYO18A,ENST00000527372,5.081,chr17,Disease|Diseases of signal transduction by growth factor receptors and second messengers|FGFR1 mutant receptor activation|FLT3 signaling in disease|Signaling by cytosolic FGFR1 fusion mutants|Signaling by FGFR1 in disease|Signaling by FGFR in disease|Signaling by FLT3 fusion proteins,actomyosin structure organization,0
NBN,ENST00000265433,1.03,chr8,Cell Cycle|Cell Cycle Checkpoints|Cellular responses to stimuli|Cellular responses to stress|Cellular Senescence|Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function|Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function|Defective homologous recombination repair (HRR) due to BRCA1 loss of function|Defective homologous recombination repair (HRR) due to BRCA2 loss of function|Defective ,blastocyst growth,0
NF1,ENST00000356175,5.318,chr17,Disease|Diseases of signal transduction by growth factor receptors and second messengers|MAPK1/MAPK3 signaling|MAPK family signaling cascades|Oncogenic MAPK signaling|RAF/MAP kinase cascade|RAS signaling downstream of NF1 loss-of-function variants|Regulation of RAS by GAPs|Signal Transduction,actin cytoskeleton organization,0
NFE2L2,ENST00000397062,4.52,chr2,Adaptive Immune System|Cellular responses to stimuli|Cellular responses to stress|Cellular response to chemical stress|Co-inhibition by PD-1|Cytoprotection by HMOX1|Disease|GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2|Heme signaling|Immune System|Infectious disease|KEAP1-NFE2L2 pathway|Metabolism of proteins|Neddylation|NFE2L2 regulates pentose phosphate pathway genes|NFE2L2 regulating anti-oxidant/detoxification enzymes|NFE2L2 regulating ER-stress associated genes|NFE2L2 regulating inflam,aflatoxin catabolic process,0
NOTCH1,ENST00000651671,0.679,chr9,Activated NOTCH1 Transmits Signal to the Nucleus|Cellular responses to stimuli|Cellular responses to stress|Cellular response to chemical stress|Constitutive Signaling by NOTCH1 HD Domain Mutants|Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants|Constitutive Signaling by NOTCH1 PEST Domain Mutants|Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant|Defective LFNG causes SCDO3|Developmental Biology|Disease|Diseases associated with O-glycosylation of proteins|Dis,angiogenesis,0
NPM1,ENST00000296930,0.623,chr5,,cellular response to UV,2
NR3C1,ENST00000231509,0.696,chr5,Gene expression (Transcription)|Generic Transcription Pathway|Nuclear Receptor transcription pathway|RNA Polymerase II Transcription,apoptotic process,14
NRAS,ENST00000369535,2.912,chr1,Activated NTRK2 signals through FRS2 and FRS3|Activated NTRK2 signals through RAS|Activated NTRK3 signals through RAS|Activation of NMDA receptors and postsynaptic events|Activation of RAS in B cells|Adaptive Immune System|Axon guidance|CD209 (DC-SIGN) signaling|Cell surface interactions at the vascular wall|Constitutive Signaling by EGFRvIII|Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants|Constitutive Signaling by Overexpressed ERBB2|CREB1 phosphorylation through NMDA receptor-,MAPK cascade,0
NTRK1,ENST00000358660,2.776,chr1,Activation of TRKA receptors|Frs2-mediated activation|Prolonged ERK activation events|Signaling by NTRK1 (TRKA)|Signaling by NTRKs|Signaling by Receptor Tyrosine Kinases|Signalling to ERKs|Signal Transduction|TRKA activation by NGF,axon guidance,4
NTRK2,ENST00000277120,0.453,chr9,Activated NTRK2 signals through CDK5|Activated NTRK2 signals through FRS2 and FRS3|Activated NTRK2 signals through FYN|Activated NTRK2 signals through PI3K|Activated NTRK2 signals through PLCG1|Activated NTRK2 signals through RAS|Activation of TRKA receptors|BDNF activates NTRK2 (TRKB) signaling|Constitutive Signaling by Aberrant PI3K in Cancer|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Intracellular signaling by second messengers|Negative regulation,brain-derived neurotrophic factor receptor signaling pathway,3
NTRK3,ENST00000317501,0.537,chr15,"Activated NTRK3 signals through PI3K|Activated NTRK3 signals through PLCG1|Activated NTRK3 signals through RAS|Constitutive Signaling by Aberrant PI3K in Cancer|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Intracellular signaling by second messengers|Negative regulation of the PI3K/AKT network|Neuronal System|NTF3 activates NTRK3 signaling|NTRK3 as a dependence receptor|PI3K/AKT Signaling in Cancer|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling|PIP3 a",animal organ development,3
OPRM1,ENST00000229768,0.513,chr6,,adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway,17
PALB2,ENST00000261584,1.065,chr16,Cellular responses to stimuli|Cellular responses to stress|Cellular response to chemical stress|Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function|Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function|Defective homologous recombination repair (HRR) due to BRCA1 loss of function|Defective homologous recombination repair (HRR) due to BRCA2 loss of function|Defective homologous recomb,DNA damage response,0
PARP1,ENST00000366794,1.026,chr1,Base Excision Repair|Disease|DNA Damage Recognition in GG-NER|DNA Double-Strand Break Repair|DNA Repair|Downregulation of SMAD2/3:SMAD4 transcriptional activity|Dual Incision in GG-NER|Formation of Incision Complex in GG-NER|Gene expression (Transcription)|Generic Transcription Pathway|Global Genome Nucleotide Excision Repair (GG-NER)|HDR through MMEJ (alt-NHEJ)|Homology Directed Repair|Infectious disease|Influenza Infection|Influenza Viral RNA Transcription and Replication|Metabolism of protein,apoptotic process,7
PARP2,ENST00000250416,2.422,chr14,Base Excision Repair|DNA Damage Recognition in GG-NER|DNA Double-Strand Break Repair|DNA Repair|Dual Incision in GG-NER|Formation of Incision Complex in GG-NER|Global Genome Nucleotide Excision Repair (GG-NER)|HDR through MMEJ (alt-NHEJ)|Homology Directed Repair|Nucleotide Excision Repair|POLB-Dependent Long Patch Base Excision Repair|Resolution of Abasic Sites (AP sites)|Resolution of AP sites via the multiple-nucleotide patch replacement pathway,decidualization,7
PBRM1,ENST00000296302,2.418,chr3,ATP-dependent chromatin remodelers|Chromatin modifying enzymes|Chromatin organization|Formation of the polybromo-BAF (pBAF) complex|Gene expression (Transcription)|Generic Transcription Pathway|RMTs methylate histone arginines|RNA Polymerase II Transcription|RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known|SWI/SNF chromatin remodelers|Transcriptional regulation by RUNX1,chromatin organization,0
PCBP1,ENST00000303577,0.681,chr2,Metabolism of RNA|mRNA Splicing|mRNA Splicing - Major Pathway|Processing of Capped Intron-Containing Pre-mRNA,positive regulation of transcription by RNA polymerase II,0
PDCD1,ENST00000334409,2.757,chr2,Adaptive Immune System|Co-inhibition by PD-1|Disease|Immune System|Infectious disease|PD-L1(CD274) glycosylation and translocation to plasma membrane|Potential therapeutics for SARS|Regulation of PD-L1(CD274) expression|Regulation of PD-L1(CD274) Post-translational modification|Regulation of T cell activation by CD28 family|SARS-CoV Infections|Viral Infection Pathways,adaptive immune response,10
PDGFRA,ENST00000257290,0.662,chr4,,cardiac myofibril assembly,11
PDGFRB,ENST00000261799,1.191,chr5,"Constitutive Signaling by Aberrant PI3K in Cancer|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downstream signal transduction|Intracellular signaling by second messengers|MAPK1/MAPK3 signaling|MAPK family signaling cascades|Negative regulation of the PI3K/AKT network|PI3K/AKT Signaling in Cancer|PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling|PIP3 activates AKT signaling|RAF/MAP kinase cascade|Signaling by PDGF|Signaling by Receptor Tyrosine Kinases|Si",angiogenesis,16
PIK3CA,ENST00000263967,3.145,chr3,Activated NTRK2 signals through PI3K|Activated NTRK3 signals through PI3K|Adaptive Immune System|Axon guidance|CD28 dependent PI3K/Akt signaling|Cell-Cell communication|Cell surface interactions at the vascular wall|Cellular responses to mechanical stimuli|Cellular responses to stimuli|Constitutive Signaling by Aberrant PI3K in Cancer|Constitutive Signaling by EGFRvIII|Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants|Co-stimulation by CD28|Co-stimulation by ICOS|Cytokine Signalin,actin cytoskeleton organization,3
PIK3R1,ENST00000320694,2.352,chr5,,B cell differentiation,0
PMS2,ENST00000265849,1.034,chr7,Defective Mismatch Repair Associated With MLH1|Defective Mismatch Repair Associated With PMS2|Disease|Diseases of DNA repair|Diseases of Mismatch Repair (MMR)|DNA Repair|Gene expression (Transcription)|Generic Transcription Pathway|Mismatch Repair|Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)|Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)|RNA Polymerase II Transcription|TP53 Regulates Transcription of DNA Repair Genes|Transcriptional Regulation by TP53,DNA damage response,0
POLA2,ENST00000265465,2.796,chr11,"Activation of the pre-replicative complex|Cell Cycle|Cell Cycle, Mitotic|Chromosome Maintenance|Defective pyroptosis|Disease|Diseases of programmed cell death|DNA Replication|DNA replication initiation|DNA Replication Pre-Initiation|DNA strand elongation|E2F mediated regulation of DNA replication|Extension of Telomeres|G1/S Transition|Inhibition of replication initiation of damaged DNA by RB1/E2F1|Lagging Strand Synthesis|Leading Strand Synthesis|Mitotic G1 phase and G1/S transition|Polymerase s",DNA replication,5
POLD1,ENST00000440232,2.05,chr19,"Base Excision Repair|Cell Cycle|Cell Cycle, Mitotic|Chromosome Maintenance|Cytosolic iron-sulfur cluster assembly|DNA Damage Bypass|DNA Double-Strand Break Repair|DNA Repair|DNA Replication|DNA strand elongation|Dual Incision in GG-NER|Dual incision in TC-NER|Extension of Telomeres|Gap-filling DNA repair synthesis and ligation in GG-NER|Gap-filling DNA repair synthesis and ligation in TC-NER|Global Genome Nucleotide Excision Repair (GG-NER)|HDR through Homologous Recombination (HRR)|HDR through ","base-excision repair, gap-filling",5
POLE,ENST00000320574,0.437,chr12,"Activation of the pre-replicative complex|Base Excision Repair|Cell Cycle|Cell Cycle, Mitotic|DNA Damage Bypass|DNA Double-Strand Break Repair|DNA Repair|DNA Replication|DNA replication initiation|DNA Replication Pre-Initiation|Dual Incision in GG-NER|Dual incision in TC-NER|G1/S Transition|Gap-filling DNA repair synthesis and ligation in GG-NER|Gap-filling DNA repair synthesis and ligation in TC-NER|Global Genome Nucleotide Excision Repair (GG-NER)|HDR through Homologous Recombination (HRR)|HDR","base-excision repair, gap-filling",5
POLE2,ENST00000216367,1.21,chr14,"Activation of the pre-replicative complex|Base Excision Repair|Cell Cycle|Cell Cycle, Mitotic|DNA Damage Bypass|DNA Double-Strand Break Repair|DNA Repair|DNA Replication|DNA replication initiation|DNA Replication Pre-Initiation|Dual Incision in GG-NER|Dual incision in TC-NER|G1/S Transition|Gap-filling DNA repair synthesis and ligation in GG-NER|Gap-filling DNA repair synthesis and ligation in TC-NER|Global Genome Nucleotide Excision Repair (GG-NER)|HDR through Homologous Recombination (HRR)|HDR",DNA metabolic process,5
PTCH1,ENST00000331920,0.363,chr9,,animal organ morphogenesis,0
PTCH2,ENST00000372192,1.169,chr1,Class B/2 (Secretin family receptors)|GPCR ligand binding|Signaling by GPCR|Signal Transduction,negative regulation of smoothened signaling pathway,0
PTEN,ENST00000371953,1.223,chr10,,adult behavior,0
PTGS1,ENST00000223423,0.52,chr9,Arachidonate metabolism|Biological oxidations|COX reactions|Fatty acid metabolism|Metabolism|Metabolism of lipids|Phase I - Functionalization of compounds|Synthesis of Prostaglandins (PG) and Thromboxanes (TX),cellular oxidant detoxification,8
PTGS2,ENST00000367468,2.18,chr1,Arachidonate metabolism|Biosynthesis of DHA-derived SPMs|Biosynthesis of DPA-derived SPMs|Biosynthesis of DPAn-3 SPMs|Biosynthesis of electrophilic -3 PUFA oxo-derivatives|Biosynthesis of EPA-derived SPMs|Biosynthesis of specialized proresolving mediators (SPMs)|Cytokine Signaling in Immune system|Fatty acid metabolism|Immune System|Interleukin-10 signaling|Interleukin-4 and Interleukin-13 signaling|Metabolism|Metabolism of lipids|Signaling by Interleukins|Synthesis of 15-eicosatetraenoic acid ,brown fat cell differentiation,10
PTPN11,ENST00000351677,1.161,chr12,,atrioventricular canal development,0
RAD51C,ENST00000337432,1.11,chr17,Cell Cycle|Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function|Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function|Defective homologous recombination repair (HRR) due to BRCA1 loss of function|Defective homologous recombination repair (HRR) due to BRCA2 loss of function|Defective homologous recombination repair (HRR) due to PALB2 loss of function|Disease|Diseases of DNA Double-Str,DNA damage response,0
RAD51D,ENST00000335858,4.203,chr17,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function|Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function|Defective homologous recombination repair (HRR) due to BRCA1 loss of function|Defective homologous recombination repair (HRR) due to BRCA2 loss of function|Defective homologous recombination repair (HRR) due to PALB2 loss of function|Disease|Diseases of DNA Double-Strand Break R,DNA damage response,0
RAF1,ENST00000251849,2.522,chr3,Adaptive Immune System|CD209 (DC-SIGN) signaling|C-type lectin receptors (CLRs)|Cytokine Signaling in Immune system|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Gain-of-function MRAS complexes activate RAF signaling|GP1b-IX-V activation signalling|Hemostasis|IFNG signaling activates MAPKs|Immune System|Innate Immune System|Interferon gamma signaling|Interferon Signaling|Ion channel transport|MAP2K and MAPK activation|MAPK1/MAPK3 signaling|MAPK family s,apoptotic process,3
RAP1B,ENST00000250559,0.452,chr12,Adaptive Immune System|Cytokine Signaling in Immune system|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation|GRB2:SOS provides linkage to MAPK signaling for Integrins|Hemostasis|Immune System|Innate Immune System|Integrin signaling|Interleukin-12 family signaling|Interleukin-12 signaling|MAP2K and MAPK activation|MAPK1/MAPK3 signaling|MAPK family signaling cascades|MET activa,adenylate cyclase-activating G protein-coupled receptor signaling pathway,0
RASA1,ENST00000274376,0.927,chr5,"Axon guidance|Developmental Biology|Downstream signal transduction|EPHB-mediated forward signaling|EPH-Ephrin signaling|MAPK1/MAPK3 signaling|MAPK family signaling cascades|Nervous system development|PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases|RAF/MAP kinase cascade|Regulation of RAS by GAPs|Signaling by Non-Receptor Tyrosine Kinases|Signaling by PDGF|Signaling by PTK6|Signaling by Receptor Tyrosine Kinases|Signaling by VEGF|Signal Transduction|VEGFA-VEGFR2 Pathway|VEGFR2 mediated cel",angiogenesis,0
RB1,ENST00000267163,1.244,chr13,"Aberrant regulation of mitotic cell cycle due to RB1 defects|Aberrant regulation of mitotic exit in cancer due to RB1 defects|Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects|Adherens junctions interactions|APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1|APC/C-mediated degradation of cell cycle proteins|Cell-Cell communication|Cell-cell junction organization|Cell Cycle|Cell Cycle, Mitotic|Cell junction organizati",aortic valve morphogenesis,0
RBM10,ENST00000329236,0.997,chrX,Metabolism of RNA|mRNA Splicing|mRNA Splicing - Major Pathway|Processing of Capped Intron-Containing Pre-mRNA,mRNA processing,0
RBX1,ENST00000216225,0.525,chr22,"Adaptive Immune System|Antigen processing: Ubiquitination & Proteasome degradation|Axon guidance|Cell Cycle|Cell Cycle Checkpoints|Cell Cycle, Mitotic|Cellular responses to stimuli|Cellular responses to stress|Cellular response to chemical stress|Cellular response to hypoxia|Circadian clock|Class I MHC mediated antigen processing & presentation|Co-inhibition by PD-1|Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants|Constitutive Signaling by NOTCH1 PEST Domain Mutants|Cytokine Signaling in ",cell population proliferation,2
RET,ENST00000340058,0.73,chr10,,axon guidance,11
RHBDF2,ENST00000313080,1.048,chr17,Anti-inflammatory response favouring Leishmania parasite infection|CD163 mediating an anti-inflammatory response|Disease|Infectious disease|Leishmania infection|Leishmania parasite growth and survival|Parasitic Infection Pathways,negative regulation of inflammatory response to antigenic stimulus,0
RNF43,ENST00000407977,0.605,chr17,Disease|Diseases of signal transduction by growth factor receptors and second messengers|Regulation of FZD by ubiquitination|Signaling by RNF43 mutants|Signaling by WNT|Signaling by WNT in cancer|Signal Transduction|TCF dependent signaling in response to WNT,negative regulation of Wnt signaling pathway,0
ROS1,ENST00000368507,1.466,chr6,,cell differentiation,1
RRM1,ENST00000300738,2.739,chr11,Interconversion of nucleotide di- and triphosphates|Metabolism|Metabolism of nucleotides,2'-deoxyribonucleotide biosynthetic process,4
RSPO1,ENST00000356545,0.379,chr1,Regulation of FZD by ubiquitination|Signaling by WNT|Signal Transduction|TCF dependent signaling in response to WNT,positive regulation of canonical Wnt signaling pathway,0
RUNX1,ENST00000300305,2.263,chr21,,cardiac muscle tissue regeneration,0
SETD2,ENST00000409792,3.577,chr3,Chromatin modifying enzymes|Chromatin organization|PKMTs methylate histone lysines,cell differentiation,0
SHC1,ENST00000368445,0.446,chr1,,angiogenesis,0
SMAD2,ENST00000262160,4.474,chr18,"Deubiquitination|Developmental Biology|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downregulation of SMAD2/3:SMAD4 transcriptional activity|Downregulation of TGF-beta receptor signaling|Formation of axial mesoderm|Formation of definitive endoderm|FOXO-mediated transcription|FOXO-mediated transcription of cell cycle genes|FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes|Gastrulation|Gene expression (Transcription)|Generic T",activin receptor signaling pathway,0
SMAD3,ENST00000327367,1.145,chr15,"Cytokine Signaling in Immune system|Deubiquitination|Developmental Biology|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downregulation of SMAD2/3:SMAD4 transcriptional activity|Downregulation of TGF-beta receptor signaling|Formation of axial mesoderm|Formation of definitive endoderm|FOXO-mediated transcription|FOXO-mediated transcription of cell cycle genes|FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes|Gastrulation|Gene ",activin receptor signaling pathway,0
SMAD4,ENST00000342988,0.456,chr18,"Adipogenesis|Cardiogenesis|Deubiquitination|Developmental Biology|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downregulation of SMAD2/3:SMAD4 transcriptional activity|Formation of definitive endoderm|FOXO-mediated transcription|FOXO-mediated transcription of cell cycle genes|FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes|Gastrulation|Gene expression (Transcription)|Generic Transcription Pathway|Germ layer formation at ga",activin receptor signaling pathway,0
SMAD7,ENST00000262158,0.762,chr18,Cytokine Signaling in Immune system|Deubiquitination|Downregulation of SMAD2/3:SMAD4 transcriptional activity|Downregulation of TGF-beta receptor signaling|Gene expression (Transcription)|Generic Transcription Pathway|Immune System|Interferon gamma signaling|Interferon Signaling|Metabolism of proteins|Post-translational protein modification|RNA Polymerase II Transcription|Signaling by BMP|Signaling by TGF-beta Receptor Complex|Signaling by TGFB family members|Signal Transduction|SMAD2/SMAD3:SMAD,adherens junction assembly,0
SMO,ENST00000249373,1.256,chr7,Activation of SMO|BBSome-mediated cargo-targeting to cilium|Cargo trafficking to the periciliary membrane|Cilium Assembly|Class B/2 (Secretin family receptors)|GPCR ligand binding|Hedgehog 'off' state|Hedgehog 'on' state|Organelle biogenesis and maintenance|Signaling by GPCR|Signaling by Hedgehog|Signal Transduction,cell surface receptor signaling pathway,5
SPOP,ENST00000347630,0.767,chr17,Adaptive Immune System|Co-inhibition by PD-1|Hedgehog 'on' state|Immune System|Regulation of PD-L1(CD274) expression|Regulation of PD-L1(CD274) Post-translational modification|Regulation of T cell activation by CD28 family|Signaling by Hedgehog|Signal Transduction|SPOP-mediated proteasomal degradation of PD-L1(CD274),proteasome-mediated ubiquitin-dependent protein catabolic process,0
SRC,ENST00000358208,0.572,chr20,Gap junction trafficking and regulation|Membrane Trafficking|Regulation of gap junction activity|Vesicle-mediated transport,angiotensin-activated signaling pathway,3
STAT3,ENST00000264657,0.754,chr17,,acute-phase response,0
STAT5A,ENST00000345506,0.896,chr17,"Cytokine Signaling in Immune system|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downstream signal transduction|Erythropoietin activates STAT5|FGFR1 mutant receptor activation|FLT3 Signaling|FLT3 signaling in disease|Growth hormone receptor signaling|Immune System|Inactivation of CSF3 (G-CSF) signaling|Interleukin-15 signaling|Interleukin-20 family signaling|Interleukin-21 signaling|Interleukin-2 family signaling|Interleukin-2 signaling|Interleukin-3, ",cell surface receptor signaling pathway via JAK-STAT,0
STK11,ENST00000326873,3.077,chr19,AMPK inhibits chREBP transcriptional activation activity|Energy dependent regulation of mTOR by LKB1-AMPK|FOXO-mediated transcription|FOXO-mediated transcription of cell death genes|Gene expression (Transcription)|Generic Transcription Pathway|Integration of energy metabolism|Metabolism|MTOR signalling|Regulation of TP53 Activity|Regulation of TP53 Activity through Phosphorylation|RNA Polymerase II Transcription|Signal Transduction|Transcriptional Regulation by TP53,activation of protein kinase activity,0
SUFU,ENST00000369899,1.22,chr10,,negative regulation of osteoblast differentiation,0
TCF7L2,ENST00000277945,2.435,chr10,,blood vessel development,0
TEK,ENST00000380036,0.65,chr9,Cell surface interactions at the vascular wall|Hemostasis|MAPK1/MAPK3 signaling|MAPK family signaling cascades|RAF/MAP kinase cascade|Signal Transduction|Tie2 Signaling,angiogenesis,2
TGFBR2,ENST00000295754,0.612,chr3,Deubiquitination|Disease|Diseases of signal transduction by growth factor receptors and second messengers|Downregulation of TGF-beta receptor signaling|Loss of Function of SMAD2/3 in Cancer|Loss of Function of TGFBR1 in Cancer|Loss of Function of TGFBR2 in Cancer|Metabolism of proteins|Post-translational protein modification|Signaling by TGF-beta Receptor Complex|Signaling by TGF-beta Receptor Complex in Cancer|Signaling by TGFB family members|Signaling by TGFBR3|Signal Transduction|SMAD2/3 Phos,activin receptor signaling pathway,0
TLN1,ENST00000314888,1.175,chr9,Axon guidance|Cellular responses to mechanical stimuli|Cellular responses to stimuli|Cellular responses to stress|Developmental Biology|Disease|Diseases of signal transduction by growth factor receptors and second messengers|GRB2:SOS provides linkage to MAPK signaling for Integrins|Hemostasis|High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells|Integrin signaling|IRE1alpha activates chaperones|MAP2K and MAPK activation|MAPK1/MAPK3 signaling|MAPK f,actin cytoskeleton organization,0
TOP1,ENST00000361337,0.34,chr20,Metabolism of proteins|Post-translational protein modification|SUMO E3 ligases SUMOylate target proteins|SUMOylation|SUMOylation of DNA replication proteins,animal organ regeneration,4
TOP2A,ENST00000423485,3.512,chr17,"Cell Cycle|Cell Cycle, Mitotic|G0 and Early G1|Metabolism of proteins|Mitotic G1 phase and G1/S transition|Post-translational protein modification|SUMO E3 ligases SUMOylate target proteins|SUMOylation|SUMOylation of DNA replication proteins|Transcription of E2F targets under negative control by DREAM complex",apoptotic chromosome condensation,15
TP53,ENST00000269305,0.398,chr17,,apoptotic process,1
TRIM24,ENST00000343526,2.876,chr7,Disease|Diseases of signal transduction by growth factor receptors and second messengers|FGFR1 mutant receptor activation|Oncogenic MAPK signaling|Signaling by BRAF and RAF1 fusions|Signaling by cytosolic FGFR1 fusion mutants|Signaling by FGFR1 in disease|Signaling by FGFR in disease,cellular response to estrogen stimulus,0
TSC1,ENST00000298552,5.367,chr9,Autophagy|Energy dependent regulation of mTOR by LKB1-AMPK|Gene expression (Transcription)|Generic Transcription Pathway|Inhibition of TSC complex formation by PKB|Macroautophagy|Membrane Trafficking|MTOR signalling|Rab regulation of trafficking|RNA Polymerase II Transcription|Signal Transduction|TBC/RABGAPs|TP53 Regulates Metabolic Genes|Transcriptional Regulation by TP53|Vesicle-mediated transport,activation of GTPase activity,0
TUBB,ENST00000327892,1.224,chr6,"Anchoring of the basal body to the plasma membrane|AURKA Activation by TPX2|Cell Cycle|Cell Cycle, Mitotic|Centrosome maturation|Cilium Assembly|Disease|G2/M Transition|Immune System|Infectious disease|Innate Immune System|Loss of Nlp from mitotic centrosomes|Loss of proteins required for interphase microtubule organization from the centrosome|Mitotic G2-G2/M phases|Mitotic Prometaphase|M Phase|Neutrophil degranulation|Organelle biogenesis and maintenance|Potential therapeutics for SARS|Recruitm",cell division,19
TUBB1,ENST00000217133,1.5,chr20,"Activation of AMPK downstream of NMDARs|Activation of NMDA receptors and postsynaptic events|Adaptive Immune System|Aggrephagy|Antiviral mechanism by IFN-stimulated genes|Asparagine N-linked glycosylation|Assembly and cell surface presentation of NMDA receptors|Autophagy|Axon guidance|Carboxyterminal post-translational modifications of tubulin|Cargo trafficking to the periciliary membrane|Cell Cycle|Cell Cycle, Mitotic|Cellular responses to stimuli|Cellular responses to stress|Chaperonin-mediate",microtubule-based process,19
TUBB2A,ENST00000333628,0.435,chr6,"Activation of AMPK downstream of NMDARs|Activation of NMDA receptors and postsynaptic events|Adaptive Immune System|Aggrephagy|Antiviral mechanism by IFN-stimulated genes|Asparagine N-linked glycosylation|Assembly and cell surface presentation of NMDA receptors|Autophagy|Axon guidance|Carboxyterminal post-translational modifications of tubulin|Cargo trafficking to the periciliary membrane|Cell Cycle|Cell Cycle, Mitotic|Cellular responses to stimuli|Cellular responses to stress|Chaperonin-mediate",cerebral cortex development,19
TUBB2B,ENST00000259818,4.647,chr6,"Activation of AMPK downstream of NMDARs|Activation of NMDA receptors and postsynaptic events|Adaptive Immune System|Aggrephagy|Antiviral mechanism by IFN-stimulated genes|Asparagine N-linked glycosylation|Assembly and cell surface presentation of NMDA receptors|Autophagy|Axon guidance|Carboxyterminal post-translational modifications of tubulin|Cargo trafficking to the periciliary membrane|Cell Cycle|Cell Cycle, Mitotic|Cellular responses to stimuli|Cellular responses to stress|Chaperonin-mediate",cerebral cortex development,19
TUBB3,ENST00000315491,0.626,chr16,"Activation of AMPK downstream of NMDARs|Activation of NMDA receptors and postsynaptic events|Adaptive Immune System|Aggrephagy|Antiviral mechanism by IFN-stimulated genes|Asparagine N-linked glycosylation|Assembly and cell surface presentation of NMDA receptors|Autophagy|Axon guidance|Carboxyterminal post-translational modifications of tubulin|Cargo trafficking to the periciliary membrane|Cell Cycle|Cell Cycle, Mitotic|Cellular responses to stimuli|Cellular responses to stress|Chaperonin-mediate",axon guidance,19
TUBB4A,ENST00000264071,0.968,chr19,"Activation of AMPK downstream of NMDARs|Activation of NMDA receptors and postsynaptic events|Adaptive Immune System|Aggrephagy|Anchoring of the basal body to the plasma membrane|Antiviral mechanism by IFN-stimulated genes|Asparagine N-linked glycosylation|Assembly and cell surface presentation of NMDA receptors|AURKA Activation by TPX2|Autophagy|Axon guidance|Carboxyterminal post-translational modifications of tubulin|Cargo trafficking to the periciliary membrane|Cell Cycle|Cell Cycle, Mitotic|C",microtubule-based process,19
TUBB4B,ENST00000340384,0.617,chr9,"Activation of AMPK downstream of NMDARs|Activation of NMDA receptors and postsynaptic events|Adaptive Immune System|Aggrephagy|Anchoring of the basal body to the plasma membrane|Antiviral mechanism by IFN-stimulated genes|Asparagine N-linked glycosylation|Assembly and cell surface presentation of NMDA receptors|AURKA Activation by TPX2|Autophagy|Axon guidance|Carboxyterminal post-translational modifications of tubulin|Cargo trafficking to the periciliary membrane|Cell Cycle|Cell Cycle, Mitotic|C",flagellated sperm motility,19
TUBB6,ENST00000317702,0.346,chr18,"Activation of AMPK downstream of NMDARs|Activation of NMDA receptors and postsynaptic events|Adaptive Immune System|Aggrephagy|Antiviral mechanism by IFN-stimulated genes|Asparagine N-linked glycosylation|Assembly and cell surface presentation of NMDA receptors|Autophagy|Axon guidance|Carboxyterminal post-translational modifications of tubulin|Cargo trafficking to the periciliary membrane|Cell Cycle|Cell Cycle, Mitotic|Cellular responses to stimuli|Cellular responses to stress|Chaperonin-mediate",microtubule-based process,19
TUBB8,ENST00000561967,3.167,chr10,"Activation of AMPK downstream of NMDARs|Activation of NMDA receptors and postsynaptic events|Adaptive Immune System|Aggrephagy|Antiviral mechanism by IFN-stimulated genes|Asparagine N-linked glycosylation|Assembly and cell surface presentation of NMDA receptors|Autophagy|Axon guidance|Carboxyterminal post-translational modifications of tubulin|Cargo trafficking to the periciliary membrane|Cell Cycle|Cell Cycle, Mitotic|Cellular responses to stimuli|Cellular responses to stress|Cilium Assembly|CO",microtubule-based process,19
TYMS,ENST00000323224,0.729,chr18,"Cell Cycle|Cell Cycle, Mitotic|G1/S-Specific Transcription|G1/S Transition|Interconversion of nucleotide di- and triphosphates|Metabolism|Metabolism of nucleotides|Mitotic G1 phase and G1/S transition",'de novo' pyrimidine nucleobase biosynthetic process,9
VCL,ENST00000211998,4.428,chr10,,adherens junction assembly,0
VEGFA,ENST00000230480,5.412,chr6,,angiogenesis,2
VHL,ENST00000256474,5.308,chr3,,amyloid fibril formation,0
VWF,ENST00000261405,1.208,chr12,,blood coagulation,0
WWOX,ENST00000355860,0.457,chr16,,apoptotic process,0
